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Abstract
The changes in N-acetylglucosaminyltransferase-V and -III (GnT-V, GnT-III) during the cell-cycle of synchronized 7721
human hepatocarcinoma cell line were investigated. Using an HPLC method to assay GnT and flow cytometry (FCM) for
cell cycle analysis, it was found that GnT-V showed the highest activity, but GnT-III reached the lowest activity when G2/M
cells were most abundant. In contrast, GnT-V declined to the minimum while GnT-III elevated to maximum when G0/G1
cells were most predominant. The opposing changes were more obvious when the activities of GnT-V and GnT-III were
expressed as relative activities (activity of GnT-V or GnT-III/the sum of activities of GnT-V plus GnT-IV plus GnT-III).
These opposing changes of GnT-V and GnT-III during the cell cycle might result from the different regulatory mechanisms
of GnT-V and GnT-III expression in the cell cycle. The alterations in the structures of cell surface N-glycans were compatible
with the changes of the activities of GnTs. The results from immunocytochemistry and Northern blot showed that the protein
and mRNA contents of GnT-V were not significantly changed during the cell cycle. The activity of a cell cycle regulating
protein kinase, p34cdc2 kinase, correlated to the activity of GnT-V. These findings suggested that the change of GnT-V
activity in cell cycle was not the consequence of the alteration of gene transcription or enzyme protein synthesis, but might be
caused by the post-translational regulation. The decrease in GnT-V and the corresponding increase in GnT-III activities were
also found after the cells were treated with all-trans retinoic acid (ATRA), and the mechanism of this might be different from
that in the cell cycle. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
UDP-N-acetylglucosamine:K-D-mannoside L-1,6-
N-acetyglucosaminyltransferase or N-acetylglucos-
aminyltransferase-V (GnT-V, EC 2.4.1.155), and
UDP-N-acetyl-glucosamine: L-D-mannoside L-1,4-
N-acetyglucosaminyltransferase or N-acetyl-glucos-
aminyltransferase-III (GnT-III, EC 2.4.1.144) are
two Golgi-located enzymes participating in the pro-
cessing of asparagine-linked glycans (N-glycans) dur-
ing the synthesis of glycoproteins. GnT-V transfers
the GlcNAc residue from UDP-GlcNAc to the K1,6-
mannoside of biantennary or triantennary N-glycans,
forming a L1,6-branching GlcNAc structure in the
products, tri- or tetra-antennary N-glycans, respec-
tively[1]. GnT-III catalyzes the transfer of a GlcNAc
residue from UDP-GlcNAc to the L1,4-mannoside in
the core portion of acceptor glycans to form a bisect-
ing L1,4-GlcNAc structure [1]. These two enzymes
had been puri¢ed and cloned [2^5], but the regula-
tions of these GnTs were not fully understood. GnT-
V was well-known as a tumorigenesis and metastasis-
related enzyme, since its product, GlcNAcL1,6-
ManK1,6-structure, was closely associated to the
metastatic potential of many cancers [6^8]. Yoshi-
mura et al. reported that when the gene encoded
GnT-III was introduced into a highly metastatic
cell line of murine melanoma, B16-hm, the lung
metastasis after intravenous injection of the GnT-
III cDNA transfected cells was signi¢cantly sup-
pressed [9]. This result was explained by the compe-
tition for substrate between the ectopically expressed
GnT-III and the intrinsic GnT-V, leading to the in-
crease in bisecting L1,4-GlcNAc and decrease in
L1,6-GlcNAc branching structure of some adhesive
proteins, including E-cadherin [10]. Therefore, GnT-
III seemed to be an anti-metastatic enzyme acting
against the e¡ects of GnT-V. It is interesting to study
whether the activities of GnT-V and GnT-III are
di¡erently or oppositely expressed in some physio-
logical or experimental conditions. The present inves-
tigation dealt with the opposing changes of GnT-V
and GnT-III in the cell cycle of a 7721 human he-
patocarcinoma cell line, and after the cells were
treated with all-trans retinoic acid (ATRA), a di¡er-
entiation-inducer of 7721 cells [11].
2. Materials and methods
2.1. Materials
The 7721 hepatocarcinoma cell line was obtained
from the Institute of Cell Biology, Academic Sinica.
RPMI 1640 medium and Trizol were purchased from
Gibco-BRL. Rabbit anti-human GnT-V antibody
and pcDNA3/GnT-V plasmid were the kind gifts
from Prof. M. Pierce at Georgia University. The
cDNA of 3-phosphoglyceraldehyde dehydrogenase
(GAPDH) was a gift from Prof. I. Shimizu at To-
kushima University. DNA restriction endonucleases
and random primer labeling kit were from Promega.
Hybond-N nylon membrane and [K-32P]dATP were
from Amersham. UDP-GlcNAc, GlcNAc, ATRA,
MES, HEPES, DTT, PMSF, Histone H1, cAMP,
PKA-inhibitor (rabbit sequence, 20 peptide), HRP-
labeled lectin, neuraminidase (Clostridium perfrin-
gens) and propidium iodide were purchased from
Sigma. The common acceptor substrate for GnT as-
say, £uorescence (AP)-labeled biantennary N-glycan
(GlcNAc2Man3GlcNAc2) was prepared by our labo-
ratory as described in the published paper [12]. Other
reagents were commercially available in China.
2.2. Cell culture, synchronization, FCM and ATRA
treatment
The 7721 cells were cultured at 37‡C, 5% CO2 in
RPMI-1640 medium containing penicillin and strep-
tomycin as previously described by our laboratory
[11]. The synchronization of the cells was performed
using serum hunger (0.5% FCS in RPMI-1640) meth-
od for 48 h. Then the cells were transferred to
RPMI-1640 medium containing 10% FCS for a fur-
ther 48 h of culture, and collected every 6 h for the
assays of GnT and p34cdc2 kinase activities, and for
other determinations as described below. After stain-
ing with propidium iodide, the cells were subjected to
FCM, and the percentage of cells at each phase of
the cell cycle was analyzed.
In the ATRA experiment, the ATRA was added to
the culture medium at di¡erent ¢nal concentration
and incubated for 48 h.
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2.3. Assay of GnTs
The activities of GnT-III, GnT-IV and GnT-V
were measured simultaneously with a routine method
in our laboratory [12], but the acceptor substrate was
increased from 100 to 800 WM. Brie£y, The reaction
mixture (50 Wl) contained 100 mM MES (pH 6.25),
800 WM £uorescence (AP)-labeled GlcNAc2Man3-
GlcNAc2, 50mM UDP-GlcNAc, 0.2M GlcNAc, 1%
Triton X-100 and 80^100 Wg enzyme protein. GnT-V
activity was assayed in the separate tube in the ab-
sence of MnCl2, but GnT-III and GnT-IV activities
were assayed together in another tube, in which
10 mM MnCl2 was added. After incubation at 37‡C
for 5 h, the reactions were stopped by heating at
100‡C for 3 min and the samples were centrifuged
at 5000 rpm in an Eppendorf tube for 15 min. An
aliquot (20 Wl) of each sample was applied to ODS
C18 column to separate the products of GnT-III,
GnT-IV and GnT-V from the acceptor substrate by
HPLC method [13]. All the samples were assayed in
duplicate. The enzyme activities were calculated ac-
cording to the peak areas of the products and
expressed as GlcNAc (pmol) transferred/h/mg pro-
tein.
2.4. Assay of p34cdc2 kinase
The enzyme activity of p34cdc2 kinase was mea-
sured according to the method reported by Lu et
al. [14]. In short, cells were homogenized by ultra-
soni¢cation in 20 mM HEPES bu¡er containing
EGTA, DTT, MgCl2, NaF, L-phosphoglycerol, leu-
peptin and PMSF. After centrifugation, 20 Wl of the
supernatant was added to 20 Wl substrate mixture
consisting of 20 mM HEPES, 5 mM EGTA, 15
mM DTT, 0.1 M L-phosphoglycerol, 0.2 mg/ml his-
tone H1, 0.1 mM ATP, 10 WM PKA-I, 107 cpm
[Q-32P]ATP, followed by incubation at 30‡C for
15 min, then subjected to SDS-PAGE (using Histone
H1 as control) after the addition of loading bu¡er
and boiling. The position of histone H1 was deter-
mined using a salting out method with 0.25 M KCl.
The visualized 32P-phosphorylated histone H1 was
cut from the gel and the cpm was counted. Enzyme
activity was expressed as pmol 32P transferred/h/mg
protein.
2.5. Cell staining with HRP^lectin complex
Cells coated on microscopic plates were treated
with PBS for 10 min, and neuraminidase (0.03 U)
for 5 h at 37‡C to remove the sialic acids at the
terminal of glycans. After washing with PBS, 0.3%
H2O2 and 1% BSA were added sequentially and in-
cubated for 30 min at each step. After washing, the
plates were incubated with 4 Wg/ml HRP^WGA or
HRP^L-PHA complex and incubated for 2 h at
37‡C, then stained with diaminobenzene (DAB). Fi-
nally, the plates were treated with gradient alcohol,
xylol and neutral gel for microscopic observation.
The intensity of the staining was quanti¢ed with Im-
age analysis, and expressed as light index.
2.6. Immunocytochemical determination of GnT-V
The avidin^biotin complex method was adopted.
The cells grown on the cover glass were ¢xed with
acetone, followed by the addition of 1:100 diluted
rabbit anti-human GnT-V antibody. After washing,
1:200 diluted biotin-labeled goat anti-rabbit IgG
antibody (second antibody) was added, then the cells
were stained with avidin^alkaline phosphatase com-
plex and NTB/BCIP staining kit. Normal rabbit se-
rum was used in the control sample instead of GnT-
V antibody. The intensity of the staining was quan-
ti¢ed with Image analysis, and expressed as light in-
dex.
2.7. Preparation of GnT-V cDNA probe
The plasmid pcDNA3/GnT-V was cut with KpnI
and XbaI, and the product, cDNA of GnT-V (2.3
kb), was separated with and recovered from agarose
electrophoresis. After puri¢cation and quanti¢cation,
it was labeled with [K-32P]dATP using a random
primer labeling kit from Promega according to the
instruction described in the manual.
2.8. Determination of GnT-V mRNA
The isolation of cell total RNA and Northern blot
were carried out according to the method described
by Sagerstrom and Sive[15]. Brie£y, cell total RNA
was extracted with Trizol, followed by formaldehyde
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denatured electrophoresis with the same amounts of
the applied RNA from di¡erent samples, then trans-
ferred to Hybond-N nylon membrane, and pre-hy-
bridization. Hybridization was performed using
K-32P-labeled cDNA of GnT-V as the probe. The
widely used cDNA of GAPDH was adopted as an
intrinsic standard during Northern blot, and was la-
beled with the same method. The intensity of each
hybridized band was quanti¢ed using a densitometer.
2.9. Protein determination
The method of Lowry et al. was used [16].
3. Results
3.1. FCM analysis of the synchronized 7721 cells and
assay of p34cdc2 kinase
After the cells were synchronized with the serum
hunger method, approximately 3/4 to 4/5 of the cells
were blocked at the G0/G1 phase. In whole cell cycle,
the G0/G1 cells were always predominant, especially
at the 0, 24 and 48 h after the cells were transferred
from 0.5 to 10% FCS containing medium, whereas,
more G2/M cells were appeared at 18 and 36 h. The
£uorescence activated cell spectra (FACS) at 0, 18,
36 and 48 h were shown in Fig. 1, and the quantita-
tive date of FACS at every 6 h were indicated in
Table 1.
In order to check the result of FCM, the activity
of p34cdc2 kinase was simultaneously determined,
since p34cdc2 kinase is an important protein partici-
pating in the regulation of cell cycle with maximal
activity at G2/M phase [16]. The data are also indi-
cated in Table 1.
3.2. Activities of GnTs at di¡erent phase of cell cycle
As shown in Table 2, the activities of all three
GnTs were variable at di¡erent phase of the cell cycle.
GnT-V activities were higher at 12, 18 and 36 h and
lower at 0, 24, 42 and 48 h, correlating with the con-
tents of G2/M cells in di¡erent phases of the cell cycle
(Fig. 2). In contrast, GnT-III activities were higher at
0, 6, 24 and 48 h and lower at 18, 30 and 36 h, which
were also in accordance with the percentages of the
G0/G1 cells in the cell cycle (Fig. 3). However, the
activity of GnT-IV, which catalyzes the transfer of
a GlcNAc residue to the K-1,4 mannoside of bianten-
nary or triantennary N-glycan to form a L1,4-branch-
ing GlcNAc structure in the products [1], seemed not
to be regularly related to the cell cycle.
3.3. Cell staining at G0/G1 and G2/M phases using
HRP^lectin
When the cells at 6 h (G0/G1 phase) and 18 h
(G2/M phase) were treated with HRP^L-PHA or
HRP^WGA, followed by DAB staining and imagine
analysis of the color intensity, it was found that the
light index was much higher at the G2/M phase with
HRP^L-PHA staining (P6 0.01), while signi¢cantly
higher at the G0/G1 phase when HRP^WGA was
used (P6 0.01) (Fig. 4).
Table 1
Analysis of cell percentages at di¡erent phase by FCM and activities of p34cdc2 kinase in the 7721 cell cycle
Time of cell culture (h) Phase of cell cyclea p34cdc2 activity (pmol/h/mg)
G0/G1 G2/M S
0 79.50 þ 5.80 9.33 þ 1.03 11.17 þ 0.78 90.1 þ 10.2
6 72.50 þ 4.75 9.80 þ 0.78 7.70 þ 0.56 88.1 þ 9.9
12 61.86 þ 3.89 10.49 þ 0.98 27.65 þ 1.35 103.2 þ 13.5
18 48.50 þ 2.07 28.30 þ 1.56 23.20 þ 1.20 359.0 þ 46.0
24 77.42 þ 5.06 13.98 þ 1.15 8.60 þ 0.75 260.0 þ 37.2
30 55.13 þ 3.37 14.04 þ 0.98 30.83 þ 1.23 271.9 þ 30.9
36 51.87 þ 3.95 25.94 þ 1.88 22.19 þ 1.78 302.6 þ 38.5
42 72.25 þ 4.13 11.03 þ 1.31 16.72 þ 1.55 95.4 þ 8.4
48 79.66 þ 6.05 6.90 þ 0.55 13.44 þ 1.85 106.7 þ 6.5
Data are expressed as mean þ S.D. of three independent experiments
aData are expressed as the percentages of the cell.
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Table 2
Activities of GlcNAc-T-III, -IV and -V in the 7721 cell cycle
Time of cell culture (h) Speci¢c activity (pmol/h/mg)
GnT-III GnT-IV GnT-V
0 148.7 þ 15.6 58.8 þ 6.5 230.1 þ 17.3
6 138.5 þ 14.3 80.4 þ 7.4 270.0 þ 20.5
12 104.2 þ 8.8 33.3 þ 4.9 358.4 þ 43.3
18 75.2 þ 6.0 40.4 þ 3.7 499.2 þ 56.3
24 114.0 þ 12.0 22.4 þ 3.5 315.1 þ 39.1
30 71.2 þ 6.4 27.3 þ 4.9 317.4 þ 33.3
36 62.7 þ 5.8 36.9 þ 4.3 372.4 þ 40.6
42 92.5 þ 10.1 14.3 þ 2.2 276.5 þ 28.0
48 142.5 þ 12.5 70.8 þ 8.1 255.0 þ 28.6
Data are expressed as mean value þ S.D. of three independent experiments.
Fig. 1. FACS of di¡erent phases in the 7721 cell cycle. G0/G1, S, G2/M represent the di¡erent phases of the 7721 cell cycle.
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3.4. Immunocytochemical determination of GnT-V
After synchronized cells were cultured for di¡erent
times and subjected to immunocytochemical determi-
nation of GnT-V using GnT-V antibody, it was
found that the intensity of the cells was unchanged
during the cell cycle (photos not shown). No signi¢-
cant di¡erence was found after image analysis (Table
3).
3.5. Determination of GnT-V mRNA
The mRNA of GnT-V in the synchronized cells
was determined at 0, 18, 36, 48 h during the culture.
No signi¢cant change was found, indicating that the
expression of GnT-V mRNA did not change during
the di¡erent phases of the cell cycle (Fig. 5).
3.6. Opposing changes of GnT-V and GnT-III after
treatment of ATRA
When 7721 cells were treated with various concen-
trations of all-trans retinoic acid (ATRA), the down-
regulation of GnT-V and up-regulation of GnT-III
were observed in a dose-dependent manner (Fig. 6).
The declined GnT-V and elevated GnT-III were sim-
ilar to the G0/G1 phase of the 7721 cell cycle.
4. Discussion
In the present studies, the serum hunger method
was adopted to synchronize the cells in order to
avoid the possible inhibition on GnTs or p34cdc2 by
some exogenous reagents used in cell synchroniza-
tion.
The results of the present investigation showed
that the intervals of the activity peaks of both
GnT-V and GnT-III were 24 h, suggesting that the
duration of one cell cycle of 7721 cells was about
24 h. This was consistent with our previous result
[11]. Besides, the activity of p34cdc2 kinase was used
to verify the result of the cell cycle analysis. In mam-
malian cells, the cell cycle is checked at two points,
Fig. 3. Analysis of the correlation between the activity of GnT-
III and the cell percentages of the G0/G1 phase. GnT-III was
determined by the HPLC methods using pyridiylaminated
GlcNAc2Man3GlcNAc2 as acceptor substrate in the presence of
Mn2. The assay method was described in Section 2. The per-
centages of cells at di¡erent phase in cell cycle were analyzed
with FCM. The correlation coe⁄cient (r) of GnT-V vs. cell per-
centage was 0.880, P6 0.01.
Table 3
Imagine analysis of GnT-V protein in the 7721 cell cycle after
immuno-histochemical determination
Time of the cell culture (h) Relative intensities
6 7959. þ 999
12 7499 þ 240
18 7463 þ 617
24 7806 þ 1915
30 7642 þ 425
36 7993 þ 661
42 6818 þ 653
48 8077 þ 1958
Data are expressed as mean value þ S.D. of three independent
experiments.
Fig. 2. Analysis of the correlation between the activity of GnT-
V and the cell percentages of the G2/M phase. GnT-V was de-
termined by the HPLC methods using pyridiylaminated
GlcNAc2Man3GlcNAc2 as acceptor substrate in the absence of
Mn2. The assay method was described in Section 2. The per-
centages of cells at di¡erent phase in cell cycle were analyzed
with FCM. The correlation coe⁄cient (r) of GnT-V vs. cell per-
centage was 0.868, P6 0.001.
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G1CS and G2CM. The p34cdc2 kinase (also called
CDK2) combines with cyclin B to form a cell matu-
ration-promoting factor (MPF), which provokes the
cell going to G2/M check point. The p34cdc2 kinase is
activated in the G2CM phase due to the dephos-
phorylation of Tyr-15 (may be included Tyr-14)
[17,18], which is compatible with our result shown
in Table 1 that the activity of p34cdc2 kinase was
highest at G2/M phase.
GnT-V activity was correlated with the percentage
of G2/M cells (correlation coe⁄cient r = 0.868), high-
er at G2/M but lower at G0/G1 phase, while GnT-III
activity was proportional with the contents of G0/G1
cells (r = 0.880), higher at G0/G1 phase and lower at
G2/M phase. When these two enzyme activities were
compared on the base of relative activities, the per-
centage of each enzyme in total GnT activity (the
sum of the activities of GnT-III plus GnT-IV plus
GnT-V), it was found that the activity changes of
GnT-V and GnT-III were opposite (r =30.951).
Generally speaking, the maximal activities of GnT-
V occurred just at the time when GnT-III activities
were the lowest, and the peaks of GnT-III activities
were at the same time of the minimal activities of
GnT-V, as it was indicated in Fig. 7. The opposing
changes of GnT-III and GnT-V during the cell cycle
were supported by the results of HRP^lectin staining
of the cells. As shown in Fig. 4, the staining with
HRP^L-PHA was more intensive at G2/M phase
(18 h) than that at G0/G1 phase (6 h); while it was
Fig. 4. HRP^lectin staining of synchronized 7721 cells. (A) Cells on the glass plate were treated with HRP^L-PHA or HRP^WGA,
and the color was developed with DAB. (B) The staining colors were analyzed with Image analyzer, and expressed as light index.
*P6 0.01 compared with the light index of the group using the same HRP^lectin.
BBAMCR 14578 17-2-00
H.-B. Guo et al. / Biochimica et Biophysica Acta 1495 (2000) 297^307 303
more obvious at G0/G1 phase when HRP^WGA was
used. It is well-known that the binding speci¢city of
L-PHA for desialylated N-glycans is for glycans con-
taining a L-1,6-GlcNAc branching structure, the
product of GnT-V, while that of WGA is the glycans
with bisecting GlcNAc, the product of GnT-III [19].
Therefore, the changes in the structure of N-glycans
were parallel with the activity variations of GnT-V
and GnT-III in the 7721 cell cycle.
The variation of GnT-V activity cannot be ex-
plained by the competition for common substrates
among the GnTs, since the activity of GnT-V was
assayed in a separate tube without Mn2, in which
GnT-IV and GnT-III were inactivated owing to the
absence of Mn2. On the other hand, both the pro-
tein and mRNA of GnT-V showed no change during
the cell cycle. Therefore, the periodic change in GnT-
V in the cell cycle did not appear to have resulted
from the alteration on the level of gene transcription
or protein synthesis. It is likely that the post-transla-
tional regulation is the main mechanism responsible
for the control of GnT-V activity in the 7721 cell
cycle. The correlation between the activity of GnT-
V and p34cdc2 kinase (r = 0.752) supports the possi-
bility that GnT-V is regulated by p34cdc2 kinase or
other protein kinases. Our laboratory has reported
that GnT-V was activated by phorbol-12-myristate-
13-acetate (PMA) as well as cAMP, and this activa-
tion was blocked by the inhibitors of protein kinase
C (PKC) and protein kinase A (PKA) or by the
treatment of the crude enzyme with phosphatase
[12]. It suggested that GnT-V activity might be regu-
lated by serine protein kinase in 7721 cells via an
indirect phosphorylation mechanism. However, the
cAMP-PKA system was not involved in the activa-
tion of GnT-III (Table 4), indicating that there are
di¡erent mechanisms in the regulation of di¡erent
GnTs. In addition to PKC and PKA, protein tyro-
sine kinase (PTK) also participated in the regulation
of basal activity of GnT-V in 7721 cells [20]. Re-
cently, we discovered that protein kinase B (PKB),
which was newly reported to participate in the sig-
naling pathway of insulin and some growth factors
(IGF-2, NGF, PDGF) [21], was another important
regulatory factor of GnT-V. However, whether TPK
and PKB were also included in the regulation of
GnT-III was unclear.
Moreover, the activity of GnT-V was down regu-
lated in A549 cells transfected with p16, a cell cycle
suppressor gene, and the GnT-V mRNA was also
not changed after p16 transfection (to be published).
This indicates that the activity change of GnT-V
during the cell cycle is not necessarily accompanied
by the alteration of the gene transcription of GnT-V.
On the other hand, we also found that the expression
of some PKC subtypes varied during the 7721 cell
Fig. 5. Determination of GnT-V mRNA. (A) Northern blot.
(B) Densitometric analysis relative absorbance unit : absorbance
of GnT-V mRNA/absorbance of GAPDH mRNA. The proce-
dure of Northern blot was brie£y described in Section 2.
Fig. 6. Opposite changes of GnT-V and GnT-III activities in
7721 cells treated with ATRA. Di¡erent concentrations of
ATRA (0.1^10 WM) were added to the culture medium of 7721
cells for 48 h before cell harvest.
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cycle (to be published), suggesting that di¡erent sub-
types of PKC might regulate GnT-V and GnT-III.
All of these ¢ndings provide the evidence that peri-
odic variation of GnT-V activity may be caused by
the periodical changes in the activities of some pro-
tein kinases that up- or down-regulate the GnT-V
activity.
The mechanism of the periodical change of GnT-
III remains unknown. It is also unlikely to be due to
the competition for substrates between GnTs, be-
cause the concentrations of both UDP-GlcNAc (20
mM) and AP-labeled GlcNAc2Man3GlcNAc2 (0.8
mM) were in far excess. It was calculated that only
less than 0.5% of the acceptor substrate was used
during the incubation time. We found that 0.8 mM
of the acceptor substrate was enough even in the
assay system, in which all of the GnTs (III+IV+V)
were increased, such as in some cancer tissues [22].
Further increase of the substrate concentration could
not abolish the variation of GnT-III activity in the
cell cycle. It was found in our laboratory that GnT-
III was also regulated by PKC in 7721 cells [23].
Therefore, it appears that GnT-III is regulated by
some other protein kinases or factors that are also
changed during the cell cycle, but changed in the
opposite direction as compared with those factors
which regulate GnT-V. Alternatively, one protein ki-
nase may regulate GnT-V and GnT-III in opposite
direction mediated by the activation or inhibition of
di¡erent regulatory proteins.
The opposing changes in GnT-V and GnT-III
were also found when the 7721 cells were treated
with all-trans retinoic acid (ATRA) for 48 h. The
reduced activities of GnT-V accompanied by elevated
activities of GnT-III at di¡erent concentrations of
ATRA suggested the resemblance between G0/G1
cells and the ATRA-treated cells. This was consistent
with our ¢nding that ATRA blocked the 7721 cells in
G0/G1 phase [11]. This ¢nding provides more evi-
dence that GnT-V and GnT-III were regulated by
di¡erent mechanisms. The mechanism of ATRA ac-
tion in the down-regulation of GnT-V was not fully
resolved, and this event may also be mediated by the
down-regulation of PKC and PTK by ATRA [24,25],
or via other cell cycle-related factors regulated by
ATRA. On the other hand, ATRA was found to
suppress the expression of some oncogenes, such as
Ras [26], which stimulated the expression of both
mRNA and activity of GnT-V after it was trans-
Fig. 7. Analysis of the opposite correlation between the relative
activities of GnT-V and GnT-III.
Relative activity  GnTÿ V or GnTÿ III
GnTÿ VGnTÿ IVGnTÿ III
Experimental conditions were the same as described in Figs. 2
and 3.
Table 4
E¡ect of cAMP and PKA inhibitor on the activities of GnT-V, GnT-III and PKA in 7721 cells
Cell group PKA (pmol/min/mg protein) GnT-V (pmol/h/mg protein) GnT-III (pmol/h/mg protein)
Control 72.2 (100.0) 230.4 (100.0) 98.8 (100.0)
Dibutyryl cAMP 36.3 (199.8) 384.4 (166.8) 105.0 (106.3)
PKA inhibitor+dibutyryl cAMP 64.2 (88.9) 256.0 (111.1) 96.7 (97.9)
Dibutyryl cAMP+ALPa ^ 85.9 (37.3) 38.7 (39.5)
Data in parentheses are the relative activities. The 7721 cells were incubated as described in Section 2, and pre-incubated with 0.5
mM dibutyryl cAMP for 30 min, or pre-incubated with 50 nM PKA inhibitor (20 peptide, rabbit sequence) for 60 min, followed by
PKA inhibitor plus 0.5 mM dibutyryl cAMP for further a 30 min. After the cells were harvested, the enzyme was prepared and the
GnTs were assayed as described in Section 2. PKA activity was determined as previously reported by our laboratory [11].
aALP (alkaline phosphatase from bovine intestine) 0.5 U was added to the enzyme assay system.
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fected into 7721 cells, as found in our laboratory. We
also found that the metastasis suppressor gene,
nm23-H1, was up-regulated by the treatment of
7721 cells with ATRA, and the expression of GnT-
V mRNA and activity suppressed by the transfection
of nm23-H1 to 7721 cells (to be published). The
above observations suggest that other mechanisms
may be present in the regulation of GnTs apart
from the e¡ects of protein kinases. It is possible
that the transcription level is the main mechanism
for GnT regulation in most physiological and patho-
logical conditions.
Another ¢nding in our laboratory revealed that
when 7721 cells were transfected with the anti-sense
cDNA of GnT-V, the decrease of GnT-V activity
was also accompanied by the increase of GnT-III
[27]. The latter could not be explained by the sup-
pression of GnT-V gene transcription. The possibility
of competition for the same substrates could not be
ruled out in this case. This competition for substrate
may take place within the cells, where the concentra-
tions of GnT substrates are very low. The transfec-
tion of GnT-III gene into B16-hm melanoma re-
sulted in the decrease of GnT-V activity and L1,6-
branching in the glycans of adhesive molecules, as
suggested by Yoshimura et al. [9], was an example
for such competition. Furthermore, the increased
GnT-III can also modify the structure of N-glycans
on some glycoproteins, such as receptor of epidermal
growth factor (EGF)[28] and nerve growth factor
(NGF) [29]. These changes will lead to the inhibition
of growth factor function or signaling dysfunction,
including decrease of receptor binding, dimerization
and tyrosine auto-phosphorylation, by the over-ex-
pression of bisecting GlcNAc on the receptor gly-
cans. These results indicated the opposite role of
GnT-III to GnT-V in the regulation of cell growth
and strongly supported that GnT-V and GnT-III
might function di¡erently in cells.
In conclusion, the opposing changes in the activ-
ities of GnT-V and GnT-III in the 7721 cell cycle are
mainly caused by the post-translational regulation,
perhaps by some protein kinase (s). These results
suggested that GnT-V and GnT-III might be regu-
lated and function di¡erently in the cell cycle. GnT-V
may be associated with the mitosis and proliferation
of 7721 cells, but the physiological signi¢cance of
GnT-III remains to be further studied.
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